Diabetic cardiomyopathy

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Diseases

Background:

• Diabetes mellitus is a significant risk factor for atherosclerosis and ischemic heart disease.
• Diabetic cardiomyopathy, characterized by cardiac dysfunction independent of coronary atherosclerosis, is increasingly recognized.
• Cardiac structural changes and impaired ventricular function occur even in well-controlled diabetes.

Purpose of the Study:

• To review the mechanisms and clinical implications of diabetic cardiomyopathy.
• To highlight the cardiac phenotype in diabetes beyond macrovascular complications.
• To discuss potential therapeutic strategies for diabetic heart disease.

Main Methods:

• Literature review of studies on diabetes and cardiac function.
• Analysis ofPathophysiological mechanisms linking diabetes to cardiac dysfunction.
• Synthesis of current understanding of diabetic cardiomyopathy.

Main Results:

• Diabetes accelerates atherosclerosis and ischemic heart disease.
• Diabetic cardiomyopathy involves ventricular remodeling and systolic/diastolic dysfunction.
• Insulin resistance, hyperglycemia, and altered fatty acid metabolism contribute to cardiac dysfunction via microvascular disease and autonomic dysfunction.

Conclusions:

• Diabetic cardiomyopathy presents a distinct cardiac phenotype in diabetes.
• Targeted therapies addressing insulin resistance and substrate metabolism are crucial.
• Integrated management combining standard cardiovascular care with diabetes-specific cardiac interventions is recommended.